InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Secures SRC Approval to Advance Acclaim-1 Trial to Higher Dose

Aug 15, 2022

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company today announced that the Safety Review Committee (“SRC”) has approved continuation of the Acclaim-1 phase 1/2 clinical trial of REQORSA(TM) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”) following a review of the first cohort of patients in the phase 1 portion of the trial. In 2020, Genprex received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC approval to advance Acclaim-1 to the higher dose in the second cohort of patients is an important milestone that further supports REQORSA’s safety profile and brings us one step closer to bringing this potentially ground-breaking gene therapy approach to treating NSCLC to the patients who need it most,” said Mark Berger, M.D., chief medical officer of Genprex. “Enrollment in Acclaim-1 remains on track to complete the phase 1 portion of the study by year end.”

To view the full press release, visit https://ibn.fm/HJ5NI

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its unique, proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). REQORSA has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. In 2020, the U.S. Food and Drug Administration (“FDA”) granted Fast Track Designation for REQORSA for NSCLC in combination therapy with AstraZeneca’s Tagrisso(R) (osimertinib) for patients with EFGR mutations whose tumors progressed after treatment with Tagrisso. In 2021, the FDA granted Fast Track Designation for REQORSA for NSCLC in combination therapy with Merck & Co’s Keytruda(R) (pembrolizumab) for patients whose disease progressed after treatment with Keytruda. For more information, visit the company’s web site at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

More News

Finding a specialist can take so long, some Ontario doctors are turning to social media: OMA
Nov 2, 2026
Finding a specialist can take so long, some Ontario doctors are turning to social media: OMA

The Ontario Medical Association says problems with accessing specialist care have led to Ontarians turning to hospital emergency departments instead.

Just 28 Travel Products Flight Attendants Have Left Rave Reviews For
Nov 2, 2026
Just 28 Travel Products Flight Attendants Have Left Rave Reviews For

Because literally who else could have better travel recs? View Entire Post ›

Eurostar Names New Chief Executive as Channel Tunnel Competition Looms
Nov 2, 2026
Eurostar Names New Chief Executive as Channel Tunnel Competition Looms

Following Gwendoline Cazenave’s departure, incoming CEO Christophe Fanichet leads Eurostar into a competitive era, expanding routes alongside Deutsche Bahn while bracing for incoming rivals Virgin and Trenitalia. The post Eurostar Names New Chief Executive as Channel Tunnel Competition Looms appeared first on Business Traveller.

Would you DARE to sleep here? Britain's most haunted hotels and inns - where guests hear children crying, spot ghostly figures and even flee in the night
Nov 2, 2026
Would you DARE to sleep here? Britain's most haunted hotels and inns - where guests hear children crying, spot ghostly figures and even flee in the night

From spine-chilling presences in your hotel room to ghouls wandering the corridors - haunted hotels in the UK lift the lid on their ghostly residents.

Below Saint Lucia: New Underwater Sculpture Park to Open This Winter
Nov 2, 2026
Below Saint Lucia: New Underwater Sculpture Park to Open This Winter

This winter, visitors will have a new reason to dive beneath the surface in Saint Lucia. Below Saint Lucia, a new underwater dive park at Anse La Verdure on the island’s southwest coast, will bring together art, culture, history and marine conservation through an immersive collection of underwater sculptures inspired by Saint Lucia’s people, heritage and national identity. Developed by DeepBlueSea, the Anse La Verdure site is the first phase of a three-part underwater sculpture park concept for divers, with future locations planned for snorkelers too, including Anse Ferre in Ciceron.

Wales puts cycling centre stage ahead of historic Tour de France Grand Départ finale in 2027
Nov 2, 2026
Wales puts cycling centre stage ahead of historic Tour de France Grand Départ finale in 2027

Visit Wales will use WTM London 2026 to preview how Cymru (Wales) will harness one of the most powerful moments in world sport: the first Tour de France stage to be held in Wales. On Sunday 4 July 2027, Stage 3 and the climax of the Grand Départ will race 223kms from Y Trallwng (Welshpool) to Caerdydd (Cardiff). On the UKinbound Pavilion at WTM, Visit Wales will announce how its 2027 marketing campaign will celebrate the experiences visitors can enjoy while cycling in Wales - turning global attention on the race into practical inspiration for bookable itineraries, touring programmes and memorable client experiences.

Smart Green Village breaks ground as Rwanda advances conservation-led tourism
Nov 2, 2026
Smart Green Village breaks ground as Rwanda advances conservation-led tourism

Rwanda marked the 21st edition of Kwita Izina with the ground-breaking of the Smart Green Village, part of the Volcanoes Community Resilience Project and Rwanda’s long-term vision for the restoration and expansion of Volcanoes National Park. The initiative is designed to ensure communities surrounding Rwanda’s national parks benefit directly from conservation and tourism-driven growth. The wider programme includes plans to expand Volcanoes National Park by approximately 3,740 hectares and establish around 6,620 hectares of buffer zones, creating additional habitat for Rwanda’s growing mountain gorilla population. The project is expected to improve livelihoods for more than 17,000 people across approximately 3,400 households while reducing human-wildlife conflict by 80 per cent. Rwanda also celebrated 21 years of Kwita Izina in 2026, with 22 baby mountain gorillas named during the annual conservation ceremony. Read the Rwanda Development Board announcement.

Ghana unveils “Experience Ghana” under the Presidential tourism initiative at WTM
Nov 2, 2026
Ghana unveils “Experience Ghana” under the Presidential tourism initiative at WTM

The “Experience Ghana” campaign is rallying on the flagship government tourism policy “The Blackstar Experience” designed to repackage and present Ghana’s film, music, cuisine, arts, fashion, literature and heritage as a unified, world-class tourism offering. The campaign positions Ghana as a vibrant, all-year destination for culture, leisure, business and investment.

World Travel & Culture Expo 2026 builds global connections for Thailand
Nov 2, 2026
World Travel & Culture Expo 2026 builds global connections for Thailand

The Tourism Authority of Thailand (TAT), under the Ministry of Tourism and Sports, together with public- and private-sector partners, concluded the World Travel & Culture Expo (WTCE) 2026, held from 29–31 October at IMPACT Exhibition & Convention Center, Muang Thong Thani. The event connected Thai, Chinese, and international businesses and partners from 18 countries through exhibitions, business matching, and industry exchange across tourism, culture, technology, sport, entertainment, and the creative industries, supporting Thailand’s position as the Tourism and Entertainment Hub of ASEAN.

Costa Rica and British Airways bring a spectacular celebration to the heart of London
Nov 2, 2026
Costa Rica and British Airways bring a spectacular celebration to the heart of London

As travel and tourism organisations from more than 135 countries gather in London for World Travel Market; Costa Rica and British Airways are bringing a spectacular celebration of the destination to the heart of the capital, transforming London’s Outernet into a fantastical showcase of Costa Rica’s biodiversity, culture and wildlife. Created in partnership with British Airways, the activation places Costa Rica centre stage during one of the most important weeks in the global travel calendar, positioning the destination in front of thousands of travel trade professionals, media and consumers as the industry descends on London.

38 Affordable But Useful Travel Products You’ll Be Oh So Smug You Bought In Advance
Nov 2, 2026
38 Affordable But Useful Travel Products You’ll Be Oh So Smug You Bought In Advance

Travel just gets easier and breezier with this portable folding stool and Skims-like base layer you can get for under $10 each. View Entire Post ›

Lufthansa Group: Kein online Check-in ohne Travel ID
Nov 2, 2026
Lufthansa Group: Kein online Check-in ohne Travel ID

Für den Check-in über die Websites und Apps von Lufthansa, Swiss, Austrian Airlines, Brussels Airlines, Air Dolomiti, Edelweiss und Discover Airlines wird schrittweise eine Travel ID erforderlich. The post Lufthansa Group: Kein online Check-in ohne Travel ID appeared first on Business Traveller.

YOUR NEWS, OUR NETWORK.

Do you have Great News you want to tell the world?

Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.

Daily Travelogue

In Daily Travelogue, we aim to provide rich content for the budget traveler. We only publish blog post that is informative and entertaining to add value to our readers’ user experience.

Newsletter